Future Perspectives for the Development of Chemotherapy for Advanced Gastric Cancer: Japanese and Global Status

被引：2
|
作者：
Higuchi, Katsuhiko [1 ]
Tanabe, Satoshi [1 ]
Azuma, Mizutomo [1 ]
Sasaki, Tohru [1 ]
Ishido, Kenji [1 ]
Koizumi, Wasaburo [1 ]
机构：
[1] Kitasato Univ, Sch Med, Dept Gastroenterol, Minami Ku, Sagamihara, Kanagawa 2520380, Japan
来源：
PATHOBIOLOGY | 2011年 / 78卷 / 06期
关键词：
Gastric cancer; Chemotherapy; Molecular target agent; Personalized therapy; PHASE-III TRIAL; ADVANCED ESOPHAGOGASTRIC CANCER; S-1 PLUS CISPLATIN; 1ST-LINE TREATMENT; FLUOROURACIL; DOXORUBICIN; METHOTREXATE; CAPECITABINE; OXALIPLATIN; MITOMYCIN;
D O I：
10.1159/000321700
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
In Japan, gastric cancer is the second leading cause of cancer-related mortality after lung cancer. Many randomized trials of various chemotherapeutic regimens have been conducted, contributing to improved outcomes in patients with advanced gastric cancer (AGC). The standard regimen for AGC is a combination of S-1 and cisplatin in Japan. Recently, new drug development has focused on molecular target agents, and personalized therapy for AGC has just begun. In patients with human epidermal growth factor receptor 2-positive AGC, trastuzumab in combination with chemotherapy improves survival. Furthermore, abundant information about the heterogeneity and biological backgrounds of AGC patients has been compiled. New strategies for the development of personalized therapy should be studied in the future. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码：334 / 342
页数：9
相关论文
共 50 条
  • [1] Future perspectives of chemotherapy for advanced gastric cancer
    Ohtsu, Atsushi
    Fuse, Nozomu
    Yoshino, Takayuki
    Tahara, Makoto
    Doi, Toshihiko
    GASTRIC CANCER, 2009, 12 : 60 - 66
  • [2] Future perspectives of chemotherapy for advanced gastric cancer
    Atsushi Ohtsu
    Nozomu Fuse
    Takayuki Yoshino
    Makoto Tahara
    Toshihiko Doi
    Gastric Cancer, 2009, 12 : 60 - 66
  • [3] Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives
    Junichi Sakamoto
    Satoshi Morita
    Yasuhiro Kodera
    Mahbubur Rahman
    Akimasa Nakao
    Cancer Chemotherapy and Pharmacology, 2004, 54 : S25 - S31
  • [4] Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives
    Sakamoto, J
    Morita, S
    Kodera, Y
    Rahman, M
    Nakao, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (Suppl 1) : S25 - S31
  • [5] Chemotherapy for locally advanced and metastatic gastric cancer: state of the art and future perspectives
    Bittoni, A.
    Maccaroni, E.
    Scartozzi, M.
    Berardi, R.
    Cascinu, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (04) : 309 - 314
  • [6] Perspectives for Personalization in Chemotherapy of Advanced Gastric Cancer
    Boku, Narikazu
    DISCOVERY MEDICINE, 2010, 9 (45) : 84 - 89
  • [7] Recent advances in chemotherapy for advanced gastric cancer in Japan
    Fujii, Masashi
    Kochi, Mitsugu
    Takayama, Tadatoshi
    SURGERY TODAY, 2010, 40 (04) : 295 - 300
  • [8] Chemotherapy for advanced gastric cancer: future perspective in Japan
    Shitara, Kohei
    GASTRIC CANCER, 2017, 20 : S102 - S110
  • [9] Optimal chemotherapy for advanced gastric cancer: is there a global consensus?
    Lordick, Florian
    Lorenzen, Sylvie
    Yamada, Yasuhide
    Ilson, David
    GASTRIC CANCER, 2014, 17 (02) : 213 - 225
  • [10] Perioperative chemotherapy for locally advanced gastric cancer in Japan: current and future perspectives
    Tokunaga, Masanori
    Sato, Yuya
    Nakagawa, Masatoshi
    Aburatani, Tomoki
    Matsuyama, Takatoshi
    Nakajima, Yasuaki
    Kinugasa, Yusuke
    SURGERY TODAY, 2020, 50 (01) : 30 - 37
12345